Search by Drug Name or NDC

    NDC 55111-0340-30 Amlodipine Besylate and Benazepril Hydrochloride 5; 20 mg/1; mg/1 Details

    Amlodipine Besylate and Benazepril Hydrochloride 5; 20 mg/1; mg/1

    Amlodipine Besylate and Benazepril Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr.Reddy's Laboratories Limited. The primary component is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE.

    Product Information

    NDC 55111-0340
    Product ID 55111-340_6fafdf6a-6153-9a62-1774-755f2bcf0cc2
    Associated GPIs 36991502200140
    GCN Sequence Number 023768
    GCN Sequence Number Description amlodipine besylate/benazepril CAPSULE 5 MG-20 MG ORAL
    HIC3 A4K
    HIC3 Description ACE INHIBITOR-CALCIUM CHANNEL BLOCKER COMBINATION
    GCN 33090
    HICL Sequence Number 010041
    HICL Sequence Number Description AMLODIPINE BESYLATE/BENAZEPRIL HCL
    Brand/Generic Generic
    Proprietary Name Amlodipine Besylate and Benazepril Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine Besylate and Benazepril Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 5; 20
    Active Ingredient Units mg/1; mg/1
    Substance Name AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
    Labeler Name Dr.Reddy's Laboratories Limited
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Ch
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077183
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0340-30 (55111034030)

    NDC Package Code 55111-340-30
    Billing NDC 55111034030
    Package 30 CAPSULE in 1 BOTTLE (55111-340-30)
    Marketing Start Date 2010-04-19
    NDC Exclude Flag N
    Pricing Information N/A